Literature DB >> 18245030

Antidepressant medications v. cognitive therapy in people with depression with or without personality disorder.

Jay C Fournier1, Robert J DeRubeis, Richard C Shelton, Robert Gallop, Jay D Amsterdam, Steven D Hollon.   

Abstract

BACKGROUND: There is conflicting evidence about comorbid personality pathology in depression treatments. AIMS: To test the effects of antidepressant drugs and cognitive therapy in people with depression distinguished by the presence or absence of personality disorder.
METHOD: Random assignment of 180 out-patients with depression to 16 weeks of antidepressant medication or cognitive therapy. Random assignment of medication responders to continued medication or placebo, and comparison with cognitive therapy responders over a 12-month period.
RESULTS: Personality disorder status led to differential response at 16 weeks; 66% v. 44% (antidepressants v. cognitive therapy respectively) for people with personality disorder, and 49% v. 70% (antidepressants v. cognitive therapy respectively) for people without personality disorder. For people with personality disorder, sustained response rates over the 12-month follow-up were nearly identical (38%) in the prior cognitive therapy and continuation-medication treatment arms. People with personality disorder withdrawn from medication evidenced the lowest sustained response rate (6%). Despite the poor response of people with personality disorder to cognitive therapy, nearly all those who did respond sustained their response.
CONCLUSIONS: Comorbid personality disorder was associated with differential initial response rates and sustained response rates for two well-validated treatments for depression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18245030      PMCID: PMC2682552          DOI: 10.1192/bjp.bp.107.037234

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  19 in total

Review 1.  Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association.

Authors: 
Journal:  Am J Psychiatry       Date:  2000-04       Impact factor: 18.112

Review 2.  Understanding emotion regulation in borderline personality disorder: contributions of neuroimaging.

Authors:  Peter A Johnson; Robin A Hurley; Chawki Benkelfat; Sabine C Herpertz; Katherine H Taber
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2003       Impact factor: 2.198

3.  Selective serotonin reuptake inhibitors decrease impulsive behavior as measured by an adjusting delay procedure in the pigeon.

Authors:  Mary C Wolff; J David Leander
Journal:  Neuropsychopharmacology       Date:  2002-09       Impact factor: 7.853

Review 4.  A general overview of Mantel-Haenszel methods: applications and recent developments.

Authors:  S J Kuritz; J R Landis; G G Koch
Journal:  Annu Rev Public Health       Date:  1988       Impact factor: 21.981

5.  Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder.

Authors:  C Salzman; A N Wolfson; A Schatzberg; J Looper; R Henke; M Albanese; J Schwartz; E Miyawaki
Journal:  J Clin Psychopharmacol       Date:  1995-02       Impact factor: 3.153

6.  Impact of Cluster C personality disorders on outcomes of contrasting brief psychotherapies for depression.

Authors:  G E Hardy; M Barkham; D A Shapiro; W B Stiles; A Rees; S Reynolds
Journal:  J Consult Clin Psychol       Date:  1995-12

7.  Depression comorbid with anxiety or medical illness: The role of paroxetine.

Authors:  F Rouillon
Journal:  Int J Psychiatry Clin Pract       Date:  2001       Impact factor: 1.812

8.  Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset.

Authors:  R D Gibbons; D Hedeker; I Elkin; C Waternaux; H C Kraemer; J B Greenhouse; M T Shea; S D Imber; S M Sotsky; J T Watkins
Journal:  Arch Gen Psychiatry       Date:  1993-09

9.  National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments.

Authors:  I Elkin; M T Shea; J T Watkins; S D Imber; S M Sotsky; J F Collins; D R Glass; P A Pilkonis; W R Leber; J P Docherty
Journal:  Arch Gen Psychiatry       Date:  1989-11

10.  The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

Authors:  M B Keller; P W Lavori; B Friedman; E Nielsen; J Endicott; P McDonald-Scott; N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1987-06
View more
  39 in total

1.  The enduring impact of maladaptive personality traits on relationship quality and health in later life.

Authors:  Marci E J Gleason; Yana Weinstein; Steve Balsis; Thomas F Oltmanns
Journal:  J Pers       Date:  2013-10-21

2.  A re-examination of process-outcome relations in cognitive therapy for depression: Disaggregating within-patient and between-patient effects.

Authors:  Katherine E Sasso; Daniel R Strunk; Justin D Braun; Robert J DeRubeis; Melissa A Brotman
Journal:  Psychother Res       Date:  2015-04-16

Review 3.  When should psychotherapy be the treatment of choice for major depressive disorder?

Authors:  John C Markowitz
Journal:  Curr Psychiatry Rep       Date:  2008-12       Impact factor: 5.285

4.  Prevalence of Personality Disorders at Midlife in a Community Sample: Disorders and Symptoms Reflected in Interview, Self, and Informant Reports.

Authors:  Thomas F Oltmanns; Merlyn M Rodrigues; Yana Weinstein; Marci E J Gleason
Journal:  J Psychopathol Behav Assess       Date:  2014-06-01

5.  The influence of personality on the treatment outcome of psychopathology.

Authors:  Roger T Mulder
Journal:  World Psychiatry       Date:  2011-06       Impact factor: 49.548

6.  The effects of sertraline on psychopathic traits.

Authors:  Boadie W Dunlop; Jared A DeFife; Lauren Marx; Steven J Garlow; Charles B Nemeroff; Scott O Lilienfeld
Journal:  Int Clin Psychopharmacol       Date:  2011-11       Impact factor: 1.659

7.  The role of personality pathology in depression treatment outcome with psychotherapy and pharmacotherapy.

Authors:  Jessica C Levenson; Meredith L Wallace; Jay C Fournier; Paola Rucci; Ellen Frank
Journal:  J Consult Clin Psychol       Date:  2012-07-23

Review 8.  Cognitive behavioral therapy for mood disorders: efficacy, moderators and mediators.

Authors:  Ellen Driessen; Steven D Hollon
Journal:  Psychiatr Clin North Am       Date:  2010-09

9.  Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial.

Authors:  Steven D Hollon; Robert J DeRubeis; Jan Fawcett; Jay D Amsterdam; Richard C Shelton; John Zajecka; Paula R Young; Robert Gallop
Journal:  JAMA Psychiatry       Date:  2014-10       Impact factor: 21.596

10.  Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy.

Authors:  E Frank; G B Cassano; P Rucci; W K Thompson; H C Kraemer; A Fagiolini; L Maggi; D J Kupfer; M K Shear; P R Houck; S Calugi; V J Grochocinski; P Scocco; J Buttenfield; R N Forgione
Journal:  Psychol Med       Date:  2010-04-12       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.